1. Home
  2. LFST vs EVO Comparison

LFST vs EVO Comparison

Compare LFST & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeStance Health Group Inc.

LFST

LifeStance Health Group Inc.

HOLD

Current Price

$7.73

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.06

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFST
EVO
Founded
2015
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
1.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
LFST
EVO
Price
$7.73
$3.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$9.83
$7.00
AVG Volume (30 Days)
6.7M
47.1K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,424,285,000.00
N/A
Revenue This Year
$17.18
$1.37
Revenue Next Year
$14.02
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
13.85
N/A
52 Week Low
$3.74
$2.31
52 Week High
$8.89
$4.42

Technical Indicators

Market Signals
Indicator
LFST
EVO
Relative Strength Index (RSI) 55.07 56.03
Support Level $6.17 $2.88
Resistance Level $8.09 $3.75
Average True Range (ATR) 0.24 0.07
MACD -0.04 0.01
Stochastic Oscillator 57.61 89.58

Price Performance

Historical Comparison
LFST
EVO

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: